ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Pulmonary Disease

Top Pulmonary Disease Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANUP BANERJEE M.D.

Pulmonary Disease

2,029

$214K

360
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 57%

$106
Average prescription price

Avg: $178

WAYNE BEAUFORD M.D.

Pulmonary Disease

2,020

$315K

303
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

76%
prescriptions for brand name drugs

Avg: 57%

$156
Average prescription price

Avg: $178

KEITH CLANCE M.D.

Pulmonary Disease

1,957

$378K

317
251 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 57%

$193
Average prescription price

Avg: $178

TIMOTHY HART MD

Pulmonary Disease

1,938

$519K

239
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 57%

$268
Average prescription price

Avg: $178

FREDERICK ZELLER MD

Pulmonary Disease

1,917

$288K

241
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 57%

$150
Average prescription price

Avg: $178

MARK POWERS M.D.

Pulmonary Disease

1,855

$279K

208
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 57%

$150
Average prescription price

Avg: $178

MARK BRADY M.D.

Pulmonary Disease

1,829

$357K

251
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 57%

$195
Average prescription price

Avg: $178

SCOTT PALMER M.D.

Pulmonary Disease

1,809

$291K

115
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 57%

$161
Average prescription price

Avg: $178

SHARAD VORA MD

Pulmonary Disease

1,774

$339K

312
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

77%
prescriptions for brand name drugs

Avg: 57%

$191
Average prescription price

Avg: $178

TRENT MCCAIN M.D.

Pulmonary Disease

1,684

$370K

237
173 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

72%
prescriptions for brand name drugs

Avg: 57%

$220
Average prescription price

Avg: $178

CHRISTOPHER POOR MD

Pulmonary Disease

1,671

$511K

311
247 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 57%

$306
Average prescription price

Avg: $178

ANGELA CONNAUGHTON MD

Pulmonary Disease

1,653

$213K

276
183 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 57%

$129
Average prescription price

Avg: $178

CARTER CHILDS MD

Pulmonary Disease

1,601

$365K

306
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

82%
prescriptions for brand name drugs

Avg: 57%

$228
Average prescription price

Avg: $178

DAVID DEFEO M.D.

Pulmonary Disease

1,572

$242K

312
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 57%

$154
Average prescription price

Avg: $178

ROBERT DIETRICH MD

Pulmonary Disease

1,518

$306K

259
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 57%

$202
Average prescription price

Avg: $178

GREGORY CAMPBELL MD

Pulmonary Disease

1,515

$377K

208
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

72%
prescriptions for brand name drugs

Avg: 57%

$249
Average prescription price

Avg: $178

HILDA METJIAN M.D.

Pulmonary Disease

1,488

$275K

248
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 57%

$185
Average prescription price

Avg: $178

MCKENDREE MCNABB M.D.

Pulmonary Disease

1,449

$89.8K

84
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 57%

$62
Average prescription price

Avg: $178

KIMBERLY MCCREA M.D.

Pulmonary Disease

1,440

$455K

178
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 57%

$316
Average prescription price

Avg: $178

DANIEL ANDERSON MD

Pulmonary Disease

1,389

$560K

196
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 57%

$403
Average prescription price

Avg: $178

OLIVER JERVIS M.D.

Pulmonary Disease

1,379

$184K

209
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 57%

$134
Average prescription price

Avg: $178

KAVITHA SRAVANTHI KADUMPALLI M.D.

Pulmonary Disease

1,373

$234K

204
140 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

79%
prescriptions for brand name drugs

Avg: 57%

$171
Average prescription price

Avg: $178

WILLIAM CREDLE MD

Pulmonary Disease

1,357

$183K

188
150 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 57%

$135
Average prescription price

Avg: $178

WILLIAM DOMBY M.D.

Pulmonary Disease

1,352

$184K

204
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$136
Average prescription price

Avg: $178

WILLIAM ERWIN MD

Pulmonary Disease

1,345

$417K

215
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 57%

$310
Average prescription price

Avg: $178

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank